KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Other Non-Current Assets (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Other Non-Current Assets for 4 consecutive years, with $97.0 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Other Non-Current Assets changed N/A year-over-year to $97.0 million, compared with a TTM value of $97.0 million through Sep 2023, changed N/A, and an annual FY2022 reading of $88.7 million, up 101.69% over the prior year.
  • Other Non-Current Assets was $97.0 million for Q3 2023 at Ginkgo Bioworks Holdings, up from $88.7 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $97.0 million in Q3 2023 and bottomed at $5.6 million in Q4 2020.
  • Average Other Non-Current Assets over 4 years is $52.4 million, with a median of $44.0 million recorded in 2021.
  • The sharpest move saw Other Non-Current Assets surged 685.12% in 2021, then surged 101.69% in 2022.
  • Year by year, Other Non-Current Assets stood at $5.6 million in 2020, then soared by 685.12% to $44.0 million in 2021, then soared by 101.69% to $88.7 million in 2022, then rose by 9.35% to $97.0 million in 2023.
  • Business Quant data shows Other Non-Current Assets for DNA at $97.0 million in Q3 2023, $88.7 million in Q4 2022, and $44.0 million in Q4 2021.